Get the Stockscreener App
3.39
1.74%
-0.06
Rocket Pharmaceuticals Inc stock is traded at $3.39, with a volume of 1.62M.
It is down -1.74% in the last 24 hours and up +2.73% over the past month.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
See More
Previous Close:
$3.45
Open:
$3.46
24h Volume:
1.62M
Relative Volume:
0.66
Market Cap:
$366.87M
Revenue:
-
Net Income/Loss:
$-258.08M
P/E Ratio:
-1.2327
EPS:
-2.75
Net Cash Flow:
$-202.32M
1W Performance:
+2.11%
1M Performance:
+2.73%
6M Performance:
+10.42%
1Y Performance:
-73.03%
1-Day Range:
$3.38
$3.54
1-Week Range:
$3.315
$3.65
52-Week Range:
$2.19
$13.35
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Name
Rocket Pharmaceuticals Inc
Sector
Industry
Phone
646-440-9100
Address
350 FIFTH AVENUE, NEW YORK, NY
Compare RCKT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.39 | 373.37M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Aug-20-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-25-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-25 | Downgrade | Evercore ISI | Outperform → In-line |
| May-28-25 | Downgrade | Goldman | Neutral → Sell |
| May-28-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-28-25 | Downgrade | Jefferies | Buy → Hold |
| May-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| May-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-27-25 | Downgrade | Needham | Buy → Hold |
| May-27-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-12-25 | Initiated | BMO Capital Markets | Outperform |
| Dec-30-24 | Initiated | Wedbush | Outperform |
| Dec-18-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Apr-02-24 | Initiated | Goldman | Neutral |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-23 | Initiated | Morgan Stanley | Overweight |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Nov-01-22 | Initiated | BTIG Research | Buy |
| Jul-08-22 | Initiated | Raymond James | Outperform |
| Oct-20-21 | Resumed | Cowen | Outperform |
| Mar-02-21 | Initiated | Stifel | Buy |
| Feb-18-21 | Initiated | Needham | Buy |
| Dec-16-20 | Initiated | UBS | Buy |
| Dec-08-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-02-20 | Initiated | JP Morgan | Overweight |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| Jun-01-20 | Resumed | Oppenheimer | Outperform |
| Nov-06-19 | Initiated | Chardan Capital Markets | Buy |
| Sep-26-19 | Initiated | Piper Jaffray | Overweight |
| Apr-23-19 | Initiated | Robert W. Baird | Outperform |
| Mar-15-19 | Initiated | BofA/Merrill | Buy |
| Feb-05-19 | Initiated | Oppenheimer | Outperform |
| Sep-13-18 | Initiated | Ladenburg Thalmann | Buy |
| Jul-10-18 | Initiated | William Blair | Outperform |
View All
Rocket Pharmaceuticals Inc Stock (RCKT) Latest News
Maverick Capital Ltd. Has $20.49 Million Stock Position in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Share Price Passes Below Fifty Day Moving AverageHere's Why - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Nasdaq Index Drives Rare-Disease Research - Kalkine Media
What analysts say about Rocket Pharmaceuticals Inc stockConsumer Goods Stocks & Small Entry Cost Investments - earlytimes.in
Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death - MSN
Forecast Cut: Can Rocket Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryPortfolio Gains Report & Free Real-Time Volume Trigger Notifications - moha.gov.vn
Is Rocket Pharmaceuticals Inc. (9IP1) stock undervalued after correctionJobs Report & High Accuracy Trade Alerts - Newser
What Wall Street predicts for Rocket Pharmaceuticals Inc. Equity Warrant stock price - Newser
Rocket Pharmaceuticals heads to Lisbon for Cardio Genomics Meeting - Traders Union
Is Rocket Pharmaceuticals Inc. (9IP1) stock among top earnings playsWeekly Profit Report & Expert Approved Trade Ideas - Newser
Will Rocket Pharmaceuticals Inc. (9IP1) stock test record highs in 20252025 Big Picture & Growth Oriented Trade Recommendations - Newser
Is Rocket Pharmaceuticals Inc. Equity Warrant stock near bottom after declineWeekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Is Rocket Pharmaceuticals Inc. stock positioned well for digital economyPortfolio Return Summary & Reliable Volume Spike Alerts - Newser
How Rocket Pharmaceuticals Inc. (9IP1) stock trades pre earnings2025 Volatility Report & Free Expert Verified Stock Movement Alerts - Newser
Is Rocket Pharmaceuticals Inc. (9IP1) stock a buy on weaknessMarket Rally & Daily Stock Trend Watchlist - Newser
Published on: 2025-12-02 03:22:04 - Newser
Published on: 2025-12-02 19:13:04 - BỘ NỘI VỤ
Class Action Alert: Levi & Korsinsky Reminds Rocket (RCKT) Investors of August 11, 2025 Deadline - The National Law Review
Securities Class Action Lawsuit Filed Against Rocket Pharmaceutic - The National Law Review
Rocket Pharmaceuticals Inc (RCKTW) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
How Rocket Pharmaceuticals Inc. Equity Warrant stock performs in weak economyWeekly Trend Recap & Daily Profit Focused Screening - BỘ NỘI VỤ
What is the fair value of Rocket Pharmaceuticals Inc. stock nowInflation Watch & Smart Allocation Stock Reports - moha.gov.vn
Will Rocket Pharmaceuticals Inc. stock deliver consistent dividendsTrade Ideas & High Accuracy Swing Trade Signals - BỘ NỘI VỤ
DEADLINE NEXT WEEK: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit (PR Newswire) - Aktiellt
How buybacks impact Rocket Pharmaceuticals Inc. stock valuePortfolio Gains Report & Weekly Hot Stock Watchlists - BỘ NỘI VỤ
Aug Big Picture: How buybacks impact Rocket Pharmaceuticals Inc. stock valueEarnings Overview Summary & Real-Time Volume Analysis Alerts - BỘ NỘI VỤ
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference - Business Wire
Skyline Ventures India Limited Moves Into Bullish Territory Based on MACDIndustrial Stocks Review & Rapid Wealth Accumulation - earlytimes.in
Why Rocket Pharmaceuticals Inc. Equity Warrant stock could be next big winner2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
Can Rocket Pharmaceuticals Inc. (9IP1) stock sustain revenue momentum2025 Top Decliners & Intraday High Probability Alerts - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock compares with top peersTrade Signal Summary & Technical Pattern Based Signals - newser.com
Is Rocket Pharmaceuticals Inc. stock entering bullish territoryWeekly Trade Summary & AI Enhanced Trade Execution Alerts - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock correlates with oil marketsPrice Action & AI Driven Stock Movement Reports - newser.com
Can Rocket Pharmaceuticals Inc. (9IP1) stock retain market dominance2025 Market Overview & Weekly Market Pulse Updates - newser.com
Amitell Capital Pte Ltd Acquires New Holdings in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Applying big data sentiment scoring on Rocket Pharmaceuticals Inc. Equity WarrantShare Buyback & AI Powered Market Entry Ideas - newser.com
Using R and stats models for Rocket Pharmaceuticals Inc. forecastingQuarterly Market Summary & Daily Stock Trend Watchlist - newser.com
Rocket Pharmaceuticals CEO Sells Shares - TradingView
CEO Shah Sells 6,276 ($18.7K) Of Rocket Pharmaceuticals Inc [RCKT] - TradingView
[Form 4] ROCKET PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Rocket Pharmaceuticals, Inc.Common Stock (Nasdaq:RCKT) Stock Quote - Markets Financial Content
How Rocket Pharmaceuticals Inc. stock reacts to inflationary pressuresWall Street Watch & Safe Capital Growth Tips - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock trades after rate cutsJuly 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
Published on: 2025-11-20 03:46:18 - newser.com
Is Rocket Pharmaceuticals Inc. stock oversold or undervalued2025 Risk Factors & Intraday High Probability Alerts - newser.com
RCKT General Counsel reports 1,646-share stock sale on Form 4 - Stock Titan
Using data models to predict Rocket Pharmaceuticals Inc. Equity Warrant stock movementJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - newser.com
What dividend safety rating applies to Rocket Pharmaceuticals Inc. (9IP1) stock2025 AllTime Highs & Technical Analysis for Trade Confirmation - newser.com
Why Rocket Pharmaceuticals Inc. (9IP1) stock could be next leader2025 Short Interest & Low Drawdown Investment Strategies - newser.com
Is it time to cut losses on Rocket Pharmaceuticals Inc. Equity WarrantTrade Risk Summary & Weekly High Return Stock Opportunities - newser.com
Risk adjusted return profile for Rocket Pharmaceuticals Inc. analyzedWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com
Rocket Pharmaceuticals Inc Stock (RCKT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):